These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 26877609)

  • 1. Glucose metabolism in gastric cancer: The cutting-edge.
    Yuan LW; Yamashita H; Seto Y
    World J Gastroenterol; 2016 Feb; 22(6):2046-59. PubMed ID: 26877609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis.
    Liu X; Wang X; Zhang J; Lam EK; Shin VY; Cheng AS; Yu J; Chan FK; Sung JJ; Jin HC
    Oncogene; 2010 Jan; 29(3):442-50. PubMed ID: 19881551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contactin 1: A potential therapeutic target and biomarker in gastric cancer.
    Chen DH; Yu JW; Jiang BJ
    World J Gastroenterol; 2015 Sep; 21(33):9707-16. PubMed ID: 26361417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic studies of human gastric cancer: review.
    Jayavelu ND; Bar NS
    World J Gastroenterol; 2014 Jul; 20(25):8092-101. PubMed ID: 25009381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric cancer: Metabolic and metabolomics perspectives (Review).
    Xiao S; Zhou L
    Int J Oncol; 2017 Jul; 51(1):5-17. PubMed ID: 28535006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug sensitivity testing platforms for gastric cancer diagnostics.
    Lau V; Wong AL; Ng C; Mok Y; Lakshmanan M; Yan B
    J Clin Pathol; 2016 Feb; 69(2):93-6. PubMed ID: 26567318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic and metabolic prediction of response to therapy in gastric cancer.
    Aichler M; Luber B; Lordick F; Walch A
    World J Gastroenterol; 2014 Oct; 20(38):13648-57. PubMed ID: 25320503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting hypoxic response for cancer therapy.
    Paolicchi E; Gemignani F; Krstic-Demonacos M; Dedhar S; Mutti L; Landi S
    Oncotarget; 2016 Mar; 7(12):13464-78. PubMed ID: 26859576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of metabolomics in diagnosis and surveillance of gastric cancer.
    Chan AW; Gill RS; Schiller D; Sawyer MB
    World J Gastroenterol; 2014 Sep; 20(36):12874-82. PubMed ID: 25278684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism.
    Xuan Y; Hur H; Ham IH; Yun J; Lee JY; Shim W; Kim YB; Lee G; Han SU; Cho YK
    Exp Cell Res; 2014 Feb; 321(2):219-30. PubMed ID: 24342832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
    Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H
    PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of phosphoglycerate mutase 1 in tumor aerobic glycolysis and its potential therapeutic implications.
    Jiang X; Sun Q; Li H; Li K; Ren X
    Int J Cancer; 2014 Nov; 135(9):1991-6. PubMed ID: 24285383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric Carcinoma: Recent Trends in Diagnostic Biomarkers and Molecular Targeted Therapies.
    Majeed W; Iftikhar A; Khaliq T; Aslam B; Muzaffar H; Atta K; Mahmood A; Waris S
    Asian Pac J Cancer Prev; 2016; 17(7):3053-60. PubMed ID: 27509928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature.
    Matboli M; El-Nakeep S; Hossam N; Habieb A; Azazy AE; Ebrahim AE; Nagy Z; Abdel-Rahman O
    World J Gastroenterol; 2016 Jul; 22(26):5896-908. PubMed ID: 27468184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice.
    Abbas M; Habib M; Naveed M; Karthik K; Dhama K; Shi M; Dingding C
    Biomed Pharmacother; 2017 Nov; 95():1082-1090. PubMed ID: 28922727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of autophagy promotes metastasis and glycolysis by inducing ROS in gastric cancer cells.
    Qin W; Li C; Zheng W; Guo Q; Zhang Y; Kang M; Zhang B; Yang B; Li B; Yang H; Wu Y
    Oncotarget; 2015 Nov; 6(37):39839-54. PubMed ID: 26497999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A metabonomic approach to chemosensitivity prediction of cisplatin plus 5-fluorouracil in a human xenograft model of gastric cancer.
    Wang X; Yan SK; Dai WX; Liu XR; Zhang WD; Wang JJ
    Int J Cancer; 2010 Dec; 127(12):2841-50. PubMed ID: 21351263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic profiling of oesophago-gastric cancer: a systematic review.
    Abbassi-Ghadi N; Kumar S; Huang J; Goldin R; Takats Z; Hanna GB
    Eur J Cancer; 2013 Nov; 49(17):3625-37. PubMed ID: 23896378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer.
    Li C; Zhang G; Zhao L; Ma Z; Chen H
    World J Surg Oncol; 2016 Jan; 14(1):15. PubMed ID: 26791262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baicalein reverses hypoxia-induced 5-FU resistance in gastric cancer AGS cells through suppression of glycolysis and the PTEN/Akt/HIF-1α signaling pathway.
    Chen F; Zhuang M; Zhong C; Peng J; Wang X; Li J; Chen Z; Huang Y
    Oncol Rep; 2015 Jan; 33(1):457-63. PubMed ID: 25333894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.